Risk of Cancer in People With Human Immunodeficiency Virus Experiencing Varying Degrees of Immune Recovery With Sustained Virological Suppression on Antiretroviral Treatment for More Than 2 Years: An International, Multicenter, Observational Cohort

Journal:

Clinical Infectious Diseases

Published:

2025-05-15

DOI:

10.1093/cid/ciaf248

Affiliations:

27

Authors:

27

Go to article

Institutions	Authors	Share
Hvidovre Hospital, Denmark	2.833333	0.10
University of New South Wales (UNSW Sydney), Australia	2.000000	0.07
Paracelsus Medical University (PMU), Austria	2.000000	0.07
Rigshospitalet, Denmark	1.833333	0.07
UCL, United Kingdom (UK)	1.000000	0.04
University Hospital of Lausanne (CHUV), UNIL, Switzerland	1.000000	0.04
Hôpital Necker-Enfants Malades, France	1.000000	0.04
Stichting HIV Monitoring (SHM), Netherlands	1.000000	0.04
Amsterdam UMC, Netherlands	1.000000	0.04
University of Modena and Reggio Emilia (UNIMORE), Italy	1.000000	0.04
ASST Santi Paolo e Carlo, Italy	1.000000	0.04
Bordeaux Population Health (BPH), France	1.000000	0.04
Vilnius University Hospital Santariskiu Klinikos (Santariškių Klinikos), VU, Lithuania	1.000000	0.04
University Hospital Basel (USB), UB, Switzerland	1.000000	0.04
European AIDS Treatment Group (EATG), Belgium	1.000000	0.04
Gilead, United States of America (USA)	1.000000	0.04
ViiV Healthcare Company USA, United States of America (USA)	1.000000	0.04
Merck - Rahway, United States of America (USA)	1.000000	0.04
San Raffaele Scientific Institute, Italy	0.500000	0.02
Vita-Salute San Raffaele University (UniSR), Italy	0.500000	0.02
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain	0.500000	0.02
Biomedical Research Networking Centers (CIBER), Spain	0.500000	0.02
Université Côte d'Azur (UniCA), France	0.500000	0.02
CHU Nice, France	0.500000	0.02
Monash University, Australia	0.500000	0.02
Alfred Hospital, Australia	0.500000	0.02
University of Copenhagen (UCPH), Denmark	0.333333	0.01

Interested in Clinical Sciences?